Cerity Partners
YDESW

Cerity Partners’s YD Bio Ltd Warrants YDESW Stock Holding History

Cerity Partners’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.2K Hold
320,089
– – ﹤0.01% 3215
2026
Q1 		$208K Hold
320,089
– – ﹤0.01% 2862
2025
Q4 		$317K Buy
320,089
+8,500
+3% +$12K ﹤0.01% 2375
2025
Q3 		$664K Buy
+311,589
New +$544K ﹤0.01% 1807

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Cerity Partners's YDESW Position: Q2 2026 in Review

Cerity Partners held its YD Bio Ltd Warrants (YDESW) position steady in Q2 2026 at 320,089 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

Cerity Partners first reported a position in YDESW in Q3 2025 and has held it in 4 quarters since. The position peaked at $664K in Q3 2025. 8 funds tracked by Wall St. Rank hold YDESW as of Q2 2026.

  • Cerity Partners held 320,089 shares of YD Bio Ltd Warrants worth $99.2K as of Q2 2026.
  • Cerity Partners left its YD Bio Ltd Warrants share count unchanged in Q2 2026.
  • YD Bio Ltd Warrants made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3215 holding.
  • Cerity Partners first reported a position in YD Bio Ltd Warrants in Q3 2025 and has held it in 4 quarters since.
  • Cerity Partners's YD Bio Ltd Warrants position peaked at $664K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.